Omission of Axillary Staging and Survival in Elderly Women With Early Stage Breast Cancer

Objectives:. Determine if axillary staging is associated with survival in elderly women with breast cancer. Background:. Axillary staging in women ≥ 70 years with early-stage breast cancer is controversial. Older randomized evidence has not shown axillary staging improves survival, but recent observ...

Full description

Bibliographic Details
Main Authors: Matthew Castelo, MD, Bettina E. Hansen, PhD, Lawrence Paszat, MD, MS, Nancy N. Baxter, MD, PhD, Adena S. Scheer, MD, MSc
Format: Article
Language:English
Published: Wolters Kluwer Health 2022-06-01
Series:Annals of Surgery Open
Online Access:http://journals.lww.com/10.1097/AS9.0000000000000159
_version_ 1797732803715006464
author Matthew Castelo, MD
Bettina E. Hansen, PhD
Lawrence Paszat, MD, MS
Nancy N. Baxter, MD, PhD
Adena S. Scheer, MD, MSc
author_facet Matthew Castelo, MD
Bettina E. Hansen, PhD
Lawrence Paszat, MD, MS
Nancy N. Baxter, MD, PhD
Adena S. Scheer, MD, MSc
author_sort Matthew Castelo, MD
collection DOAJ
description Objectives:. Determine if axillary staging is associated with survival in elderly women with breast cancer. Background:. Axillary staging in women ≥ 70 years with early-stage breast cancer is controversial. Older randomized evidence has not shown axillary staging improves survival, but recent observational studies have been mixed and widespread de-implementation of the practice has not occurred. Methods:. This was a population-based cohort study using the Surveillance, Epidemiology, and End Results registry. Women ≥ 70 years diagnosed with T1–T2 invasive breast cancer from 2005 to 2015 were included. Overlap propensity score weighting was used to adjust for confounders. Overall survival (OS) was determined and hazard ratios (HRs) reported with 95% confidence intervals (CIs). Breast cancer-specific survival (BCSS) was determined using competing risks analysis and subdistribution hazard ratios (sdHRs) reported. Additional adjustment was performed for receipt of chemotherapy and radiotherapy. Results:. One hundred forty-four thousand three hundred twenty-nine elderly women were included, of whom 22,621 (15.7%) did not undergo axillary staging. After overlap propensity score weighting, baseline characteristics were well balanced between the 2 groups. Women who did not undergo axillary staging were significantly less likely to receive chemotherapy (adjusted relative risk, 0.58; 95% CI, 0.54–0.62) or radiotherapy (adjusted relative risk, 0.53; 95% CI, 0.52–0.54), and had significantly worse OS (adjusted HR, 1.22; 95% CI, 1.19–1.25), and BCSS (adjusted sdHR, 1.14; 95% CI, 1.08–1.21) compared to those that had staging. Conclusions:. These findings suggest elderly women with early-stage breast cancer who do not undergo axillary staging experience worse outcomes. Reasons for this disparity may be multifactorial and require further investigation.
first_indexed 2024-03-12T12:19:48Z
format Article
id doaj.art-9509431d461044f3b56ddfecd6031097
institution Directory Open Access Journal
issn 2691-3593
language English
last_indexed 2024-03-12T12:19:48Z
publishDate 2022-06-01
publisher Wolters Kluwer Health
record_format Article
series Annals of Surgery Open
spelling doaj.art-9509431d461044f3b56ddfecd60310972023-08-30T06:09:58ZengWolters Kluwer HealthAnnals of Surgery Open2691-35932022-06-0132e15910.1097/AS9.0000000000000159202206000-00008Omission of Axillary Staging and Survival in Elderly Women With Early Stage Breast CancerMatthew Castelo, MD0Bettina E. Hansen, PhD1Lawrence Paszat, MD, MS2Nancy N. Baxter, MD, PhD3Adena S. Scheer, MD, MSc4From the * Division of General Surgery, Department of Surgery, University of Toronto, Toronto, ON, Canada† Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada† Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada† Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, CanadaFrom the * Division of General Surgery, Department of Surgery, University of Toronto, Toronto, ON, CanadaObjectives:. Determine if axillary staging is associated with survival in elderly women with breast cancer. Background:. Axillary staging in women ≥ 70 years with early-stage breast cancer is controversial. Older randomized evidence has not shown axillary staging improves survival, but recent observational studies have been mixed and widespread de-implementation of the practice has not occurred. Methods:. This was a population-based cohort study using the Surveillance, Epidemiology, and End Results registry. Women ≥ 70 years diagnosed with T1–T2 invasive breast cancer from 2005 to 2015 were included. Overlap propensity score weighting was used to adjust for confounders. Overall survival (OS) was determined and hazard ratios (HRs) reported with 95% confidence intervals (CIs). Breast cancer-specific survival (BCSS) was determined using competing risks analysis and subdistribution hazard ratios (sdHRs) reported. Additional adjustment was performed for receipt of chemotherapy and radiotherapy. Results:. One hundred forty-four thousand three hundred twenty-nine elderly women were included, of whom 22,621 (15.7%) did not undergo axillary staging. After overlap propensity score weighting, baseline characteristics were well balanced between the 2 groups. Women who did not undergo axillary staging were significantly less likely to receive chemotherapy (adjusted relative risk, 0.58; 95% CI, 0.54–0.62) or radiotherapy (adjusted relative risk, 0.53; 95% CI, 0.52–0.54), and had significantly worse OS (adjusted HR, 1.22; 95% CI, 1.19–1.25), and BCSS (adjusted sdHR, 1.14; 95% CI, 1.08–1.21) compared to those that had staging. Conclusions:. These findings suggest elderly women with early-stage breast cancer who do not undergo axillary staging experience worse outcomes. Reasons for this disparity may be multifactorial and require further investigation.http://journals.lww.com/10.1097/AS9.0000000000000159
spellingShingle Matthew Castelo, MD
Bettina E. Hansen, PhD
Lawrence Paszat, MD, MS
Nancy N. Baxter, MD, PhD
Adena S. Scheer, MD, MSc
Omission of Axillary Staging and Survival in Elderly Women With Early Stage Breast Cancer
Annals of Surgery Open
title Omission of Axillary Staging and Survival in Elderly Women With Early Stage Breast Cancer
title_full Omission of Axillary Staging and Survival in Elderly Women With Early Stage Breast Cancer
title_fullStr Omission of Axillary Staging and Survival in Elderly Women With Early Stage Breast Cancer
title_full_unstemmed Omission of Axillary Staging and Survival in Elderly Women With Early Stage Breast Cancer
title_short Omission of Axillary Staging and Survival in Elderly Women With Early Stage Breast Cancer
title_sort omission of axillary staging and survival in elderly women with early stage breast cancer
url http://journals.lww.com/10.1097/AS9.0000000000000159
work_keys_str_mv AT matthewcastelomd omissionofaxillarystagingandsurvivalinelderlywomenwithearlystagebreastcancer
AT bettinaehansenphd omissionofaxillarystagingandsurvivalinelderlywomenwithearlystagebreastcancer
AT lawrencepaszatmdms omissionofaxillarystagingandsurvivalinelderlywomenwithearlystagebreastcancer
AT nancynbaxtermdphd omissionofaxillarystagingandsurvivalinelderlywomenwithearlystagebreastcancer
AT adenasscheermdmsc omissionofaxillarystagingandsurvivalinelderlywomenwithearlystagebreastcancer